Examples of 'imatinib mesylate' in a sentence
Meaning of "imatinib mesylate"
imatinib mesylate: Likely a specific term related to pharmaceuticals or medical science. Further information or context is needed to offer a more precise definition
How to use "imatinib mesylate" in a sentence
Basic
Advanced
imatinib mesylate
Imatinib mesylate treatment was reinitiated postoperatively.
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
Several exemplary imatinib mesylate tablet formulations are given below.
The active substance is imatinib mesylate.
Alpha form of imatinib mesylate and process for its preparation.
Stabilized amorphous forms of imatinib mesylate.
Various imatinib mesylate particles morphologies can be achieved by appropriate control of processing conditions.
The compositions of the invention comprise imatinib mesylate or a salt thereof.
Imatinib mesylate is often associated with edema and occasionally serious fluid retention.
This difference in absorption observed with conventional imatinib mesylate formulations is undesirable.
Imatinib mesylate is an inhibitor of the tyrosine kinase of KIT receptors.
URF comprises an organic or organoaqueous solution of imatinib mesylate with stabilizers onto a cryogenic substrate.
The role of imatinib mesylate in pediatric GIST is being studied at this time.
Have reported two cases of hepatitis occurring during the treatment of CML with imatinib mesylate.
The solid form of imatinib mesylate in Gleevec is beta crystalline.
See also
More specifically, the invention relates to nanoparticulate imatinib mesylate compositions.
The efficacy of Imatinib mesylate was similar in older and younger patients.
Introduction, chronic myeloid leukemia has imatinib mesylate as first-line therapy.
Imatinib mesylate is sometimes associated with GI irritation.
The preferred salt of imatinib is imatinib mesylate which has the formula,.
Imatinib mesylate has the chemical structure shown below,.
The composition of claim 1, wherein the pharmaceutically acceptable salt of imatinib is imatinib mesylate.
Phase II trial of imatinib mesylate and hydroxyurea for grade III malignant gliomas.
A multi-drug composition of the present description comprises anagrelide and imatinib or imatinib mesylate.
Standard Curve with Imatinib Mesylate Standards containing imatinib mesylate were prepared as follows.
Furthermore, both forms are thermodynamically more stable than the amorphous form of Imatinib mesylate.
Imatinib mesylate is a white to off-white to brownish or yellowish tinged crystalline powder.
The invention provides a novel, polymorphic form of Imatinib mesylate and a process for its preparation.
Similarly, imatinib mesylate effectively suppressed the development of fibrosis in the infected mice.
Kinase inhibitors for example flavoperidol, imatinib mesylate or gefitinib ;.
Alternatively, imatinib mesylate particles can be contacted with one or more surface stabilizers after attrition.
The pharmaceutical composition of claim 20, wherein said anti-neoplastic agent is imatinib mesylate.
The Imatinib mesylate has the formula given below Background of the invention,.
The composition for use as defined in claim 1-3, wherein the imatinib is imatinib mesylate.
Imatinib mesylate ( im ) was the first targeted therapy for cml, representing a breakthrough in clinical practice.
Such therapeutic agents include various chemotherapeutic agents and imatinib mesylate ( GLEEVEC ® ).
Imatinib Mesylate ( amorphous form ) is blended with excipients as follows.
The ' 684 patent does not describe nanoparticulate compositions of imatinib mesylate.
Imatinib mesylate must be introduced immediately in cases with the FIP1L1/PDGFR? rearrangement.
The patient was treated with 400 mg / day of imatinib mesylate preoperatively for 5 months.
Imatinib mesylate ( GLEEVEC ® ) is one example of a PDGFR inhibitor.
The composition for use as in claim 8, wherein the amount of imatinib mesylate is 400 mg / day.
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1, A phase 2 trial.
They usually begin treatment with imatinib mesylate ( Gleevec ® ).
Imatinib mesylate has the molecular formula ( formula I ), Surface Stabilizers.
In a further embodiment embodiment, the tyrosine kinase inhibitor is imatinib mesylate or SU11248.
Imatinib mesylate ( Gleevec ) is the salt form ( mesylate ) of an older medicine, imatinib.
Most patients with PDGFR? rearrangements respond to imatinib mesylate at a dose of 100 mg / day.
Thus, GLEEVEC/STI-571 imatinib mesylate does not substantially penetrate the blood brain barrier.
You'll also be interested in:
Examples of using Mesylate
Show more
Eribulin mesylate has the following structure
Suitable alkylating agents are such as alkylhalides or mesylate
Deferoxamine mesylate is sometimes also referred to as desferal
Examples of using Imatinib
Show more
Imatinib is mainly metabolised through the liver
Medical experience with imatinib overdose is limited
Imatinib medac is indicated for the treatment of
